The U.S. health-care system is at a crossroads. Generic drugs and biosimilars have the potential to reduce costs and improve ...

Indian pharmaceutical companies, which benefited from sector tailwinds such as stable generic pricing and shortage-led ...

The direct to patients channel will also help pharmaceutical manufacturers to regain their share from generics. For example, according to a Reuters report, Arimidex reported sales of $880 million ...

The differences between the generics industry and other pharma companies wouldn’t exist without patents – legal titles that exclude others from producing or using an invention or innovation ...

The monopoly of some drug companies will be cancelled and the Health Ministry will look towards generic medication to control ...

Alkem Laboratories transfers trade generics business to Alkem Wellness Limited, aiming for growth and market expansion, maintaining shareholding pattern.

Novartis is seeking to prevent the entry of generics for its blockbuster heart failure drug Entresto, its top-selling asset ...

Teva Pharmaceutical Industries said on Thursday it will transfer ownership of its business venture that sold generics in ...